{"company":{"id":1838243,"name":"Travere","domain":"travere.com","url":"https://alion.io/company/travere"},"answer":"As of Nov 15, 2026, Alion lists 10 companies most like Travere: Amylyx, Rhythm Pharmaceuticals, Stoke Therapeutics, Neurocrine Biosciences, Liquidia, Vertex Pharmaceuticals, BioMarin Pharmaceutical Inc., Scholar Rock, Disc Medicine and PTC Therapeutics.","highlights":["Travere itself has 27 open roles on Alion.","Of them, Vertex Pharmaceuticals is hiring the most, with 226 open roles.","Stoke Therapeutics has raised the most venture funding on record: $90M."],"as_of":"2026-11-15","cite":"Alion, \"Travere competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 15, 2026. https://alion.io/company/travere/competitors","indexable":true,"target":{"name":"Travere","url":"https://alion.io/company/travere","domain":"travere.com","open_roles":27,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"San Diego","country":"US"},"technologies":["GCP","GMP","Microsoft Entra ID"],"hiring_countries":["US"],"similarity":null},"competitors":[{"name":"Amylyx","url":"https://alion.io/company/amylyx","domain":"amylyx.com","open_roles":43,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Cambridge","country":"US"},"technologies":["Wolfram","CAPA","GCP"],"hiring_countries":["US"],"similarity":{"score":16,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["Tableau","GCP","Power BI","Microsoft Excel","GMP"],"same_hq_country":true}},{"name":"Rhythm Pharmaceuticals","url":"https://alion.io/company/rhythmtx","domain":"rhythmtx.com","open_roles":28,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"San Francisco","country":"US"},"technologies":["GMP","Veeva","GCP"],"hiring_countries":["US","JP","NL"],"similarity":{"score":15.95,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["GCP","Power BI","Microsoft Excel","GMP","CDISC"],"same_hq_country":true}},{"name":"Stoke Therapeutics","url":"https://alion.io/company/stoketherapeutics","domain":"stoketherapeutics.com","open_roles":19,"open_roles_change":null,"funding":{"total_raised_usd":90000000,"last_round":"venture","last_round_usd":90000000,"last_round_date":"2018-10-22","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Bedford","country":"US"},"technologies":["Veeva","Microsoft Excel","GMP"],"hiring_countries":["US"],"similarity":{"score":15.2,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["GCP","Azure","Microsoft Entra ID","Microsoft Excel","GMP"],"same_hq_country":true}},{"name":"Neurocrine Biosciences","url":"https://alion.io/company/neurocrine","domain":"neurocrine.com","open_roles":79,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"San Diego","country":"US"},"technologies":["Veeva","SAP BusinessObjects","Oracle"],"hiring_countries":["US","CH","GB"],"similarity":{"score":14.15,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["PowerShell","Tableau","GCP","Power BI","Azure"],"same_hq_country":true}},{"name":"Liquidia","url":"https://alion.io/company/liquidia","domain":"liquidia.com","open_roles":11,"open_roles_change":null,"funding":{"total_raised_usd":69662604,"last_round":"venture","last_round_usd":21737613,"last_round_date":"2021-04-13","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Morrisville","country":"US"},"technologies":["Good Clinical Practice","CAPA","GCP"],"hiring_countries":["US"],"similarity":{"score":14,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["GCP","Azure","Microsoft Excel","Good Clinical Practice","CAPA"],"same_hq_country":true}},{"name":"Vertex Pharmaceuticals","url":"https://alion.io/company/vrtx","domain":"vrtx.com","open_roles":226,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Boston","country":"US"},"technologies":["GCP","AI Agents","Python"],"hiring_countries":["US","GB","NL"],"similarity":{"score":13.88,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["PowerShell","Tableau","GCP","ChatGPT","Power BI"],"same_hq_country":true}},{"name":"BioMarin Pharmaceutical Inc.","url":"https://alion.io/company/biomarin-pharmaceutical-inc","domain":"biomarin.com","open_roles":57,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"501-1000","headquarters":{"city":"San Rafael","country":"US"},"technologies":["GMP","Microsoft Excel","CAPA"],"hiring_countries":["US","IE","GB"],"similarity":{"score":13.8,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["Tableau","ChatGPT","Power BI","Azure","AWS"],"same_hq_country":true}},{"name":"Scholar Rock","url":"https://alion.io/company/scholarrock","domain":"scholarrock.com","open_roles":34,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Cambridge","country":"US"},"technologies":["Microsoft Excel","GCP","Power BI"],"hiring_countries":["US","CH","IE"],"similarity":{"score":13.65,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["Tableau","GCP","Power BI","Azure","Platform Engineering"],"same_hq_country":true}},{"name":"Disc Medicine","url":"https://alion.io/company/discmedicine","domain":"discmedicine.com","open_roles":15,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Watertown","country":"US"},"technologies":["GCP","Microsoft Excel","DLP"],"hiring_countries":["US"],"similarity":{"score":13.6,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["GCP","Azure","Microsoft Excel","Good Clinical Practice"],"same_hq_country":true}},{"name":"PTC Therapeutics","url":"https://alion.io/company/ptcbio","domain":"ptcbio.com","open_roles":25,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Warren","country":"US"},"technologies":["GMP","GCP","Good Clinical Practice"],"hiring_countries":["US","IE","JP"],"similarity":{"score":13.55,"shared_segments":["Rare Disease Therapeutics"],"shared_technologies":["Tableau","GCP","Power BI","Microsoft Excel","GMP"],"same_hq_country":true}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/travere/competitors","json_url":"https://alion.io/company/travere/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-15T03:04:16Z","generated_at":"2026-11-18T19:12:42Z"}}